Although I've been blogging alot about dichloroacetate, the small molecule chemotherapeutic agent that has shown promise against a variety of cancers in preclinical animal tumor models, but I'm not the only one. Fellow ScienceBlogger Abel Pharmboy, whose knowledge of pharmacology surpasses my own, has also been on the case and has produced some articles worth checking out:
The dichloroacetate (DCA) cancer kerfuffle
Where to buy dichloroacetate...
Local look at dichloroacetate (DCA) hysteria
Edmonton pharmacist asked to stop selling dichloroacetate (DCA)
Four days, four dichloroacetate (DCA) newspaper articles
More like this
Yes, I know that my blog buddy Abel wrote a post with almost exactly the same title as this. No, I'm not mindlessly aping him. I'm doing it because of what Abel revealed in his post: That most of his referrals lately have been Google searches looking for information on where to buy dichloroacetate…
Since DaveScot has made an appearance or two in the comments here, annoying everyone he comes in contact with, it's worth pointing out that mine isn't the only cluestick that could be used to pound some science into him about dichloroacetate, the supposed "cure" for cancer that's being "ignored" or…
I've written a lot about dichloroacetate, a.k.a. DCA (my last post here, along with links to my previous posts), the small molecule drug that burst onto the scene after Evangelos Michelakis of the University of Alberta published a paper in Cancer Cell in January describing strong anti-tumor…
At the risk of irritating a fellow ScienceBlogger again, I thought I'd point out this little post forwarded to me by Norm Jenson as yet another example of exactly the inflated hype for dichloroacetate as a "cure for cancer" that will "never see the light of day" because it has little profit…